Ernexa Therapeutics Inc. (ERNA)

NASDAQ: ERNA · Real-Time Price · USD

1.680

-0.110 (-6.15%)

At close: Nov 13, 2026, 4:00 PM EST

1.850

+0.170 (10.12%)

After-hours: Nov 13, 2026, 6:48 PM EST

Ernexa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.58	1.88	1.73	7.58	11.45	16.99
Cash & Short-Term Investments	5.58	1.88	1.73	7.58	11.45	16.99
Cash Growth	82.97%	8.96%	-77.18%	-33.82%	-32.61%	942.02%
Other Receivables	0.06	0.85	0.44	0.43	0.95	0.68
Receivables	0.06	0.85	0.44	0.43	0.95	0.68
Prepaid Expenses	1.1	0.4	0.19	1.6	1.28	1.1
Total Current Assets	6.73	3.13	2.35	9.6	13.68	18.77
Property, Plant & Equipment	0.35	0.55	0.76	33.27	1.27	3.24
Long-Term Investments	-	-	-	-	0.06	1
Goodwill	-	2.04	2.04	2.04	2.04	2.04
Long-Term Deferred Charges	-	-	-	-	-	5.99
Other Long-Term Assets	0.03	0.11	0.12	4.22	5.23	0.49
Total Assets	7.1	5.83	5.27	49.13	22.28	31.53

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.36	1.13	1.72	1.07	1.62	1.76
Accrued Expenses	0.77	0.56	0.68	2.88	4.1	1.01
Current Portion of Leases	0.17	0.21	0.21	2.22	0.3	0.43
Current Income Taxes Payable	-	0	0	0	-	-
Current Unearned Revenue	-	-	-	0.19	-	-
Other Current Liabilities	0.31	1.21	0.32	0.22	1.64	0.49
Total Current Liabilities	2.61	3.11	2.94	6.57	7.65	3.68
Long-Term Debt	-	-	-	6.77	-	-
Long-Term Leases	0.14	0.28	0.48	32.85	0.89	2.3
Long-Term Unearned Revenue	-	-	-	0.39	-	-
Other Long-Term Liabilities	0	0.04	0.15	0.31	1.63	0.05
Total Liabilities	2.75	3.43	3.57	46.9	10.17	6.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.04	0.02	0.03	0.03	0.01
Additional Paid-In Capital	262.44	248	233.22	189.19	177.38	166.19
Retained Earnings	-258.1	-245.64	-231.54	-186.98	-165.3	-140.7
Total Common Equity	4.35	2.4	1.7	2.23	12.11	25.5
Shareholders' Equity	4.35	2.4	1.7	2.23	12.11	25.5
Total Liabilities & Equity	7.1	5.83	5.27	49.13	22.28	31.53

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.31	0.49	0.68	41.84	1.18	2.72
Net Cash (Debt)	5.27	1.39	1.05	-34.27	10.26	14.26
Net Cash Growth	111.06%	33.40%	-	-	-28.03%	-
Net Cash Per Share	5.62	5.53	28.71	-2418.18	-	-
Filing Date Shares Outstanding	1.69	1.17	0.14	0.01	0.01	0.01
Total Common Shares Outstanding	1.65	0.31	0.14	0.01	0.01	0.01
Working Capital	4.11	0.02	-0.59	3.03	6.03	15.09
Book Value Per Share	2.64	7.64	12.41	154.70	885.46	3676.76
Tangible Book Value	4.35	0.36	-0.34	0.19	10.06	23.46
Tangible Book Value Per Share	2.64	1.13	-2.51	13.03	735.96	3382.06
Machinery	-	0.22	0.26	0.33	0.27	0.41
Leasehold Improvements	-	0.07	-	0.27	-	0.46

SEC Filings: 10-K · 10-Q